The current stock price of SRXH is 0.1991 USD. In the past month the price decreased by -58.52%. In the past year, price decreased by -90.52%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MGRX | MANGOCEUTICALS INC | N/A | 13.80M |
SRx Health Solutions, Inc. operates as a global health and wellness company. The company is headquartered in North Palm Beach, Florida and currently employs 10 full-time employees. The company went IPO on 2010-06-16. The firm offers a portfolio of pet health and wellness products for dogs and cats sold under its Halo brand in multiple forms, including foods, treats, toppers, dental products, chews and supplements. Its products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. The company offers products in different channels: Digital, which includes the sale of products to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of products to pet specialty retailers, independent pet stores, and regional distributors; and International, which includes the sale of products to foreign distribution partners and to select international retailers. The firm also operates a specialty pharmacy business through its wholly-owned subsidiary SRx Health Solutions (Canada) Inc.
SRX HEALTH SOLUTIONS INC
801 Us Highway 1
North Palm Beach FLORIDA US
CEO: Scott Lerner
Employees: 10
Phone: 18137924352
SRx Health Solutions, Inc. operates as a global health and wellness company. The company is headquartered in North Palm Beach, Florida and currently employs 10 full-time employees. The company went IPO on 2010-06-16. The firm offers a portfolio of pet health and wellness products for dogs and cats sold under its Halo brand in multiple forms, including foods, treats, toppers, dental products, chews and supplements. Its products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. The company offers products in different channels: Digital, which includes the sale of products to online retailers such as Amazon and Chewy; Brick & Mortar, which includes the sale of products to pet specialty retailers, independent pet stores, and regional distributors; and International, which includes the sale of products to foreign distribution partners and to select international retailers. The firm also operates a specialty pharmacy business through its wholly-owned subsidiary SRx Health Solutions (Canada) Inc.
The current stock price of SRXH is 0.1991 USD. The price decreased by -0.95% in the last trading session.
SRXH does not pay a dividend.
SRXH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
SRXH stock is listed on the NYSE Arca exchange.
SRX HEALTH SOLUTIONS INC (SRXH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.33).
ChartMill assigns a fundamental rating of 3 / 10 to SRXH. Both the profitability and the financial health of SRXH get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months SRXH reported a non-GAAP Earnings per Share(EPS) of -1.33. The EPS increased by 93.37% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.77% | ||
| ROA | 19.91% | ||
| ROE | 411.06% | ||
| Debt/Equity | 10.94 |
7 analysts have analysed SRXH and the average price target is 10.2 USD. This implies a price increase of 5023.05% is expected in the next year compared to the current price of 0.1991.